Skip to Content

Diabetes Simplified is a continuing medical education (CME) program focused on practical interpretations of the Diabetes Canada Clinical Practice Guidelines (CPG). Our 2024 program features topics from the 2023 Clinical Practice Guidelines update, along with Diabetes Every Day: a case-based review of select topics seen frequently in clinical practice.

Program topics:

  1. Pharmacotherapy Refresher and Update
  2. Hypoglycemia
  3. Diabetes Everyday:  Initiating Insulin
  4. Diabetes Everyday:  Beyond Basal Insulin
  5. Diabetes Everyday:  Glucose Monitoring
  6. Equity in Practice Panel Discussion

  • Members: $40
  • Non-members: $50

Diabetes Simplified

Location Details

August 10, 2024
9:00 a.m. - 1:00 p.m. ET

Online event

Get Directions

About the event


1. Anti-Hyperglycemic Agents & How to Tailor Treatment in Type 2 Diabetes

  • Discuss the role of the SGLT2 inhibitors in people with Type 2 Diabetes and heart failure with preserved ejection fraction (HFpEF)
  • Examine the current KDIGO 2022 guidelines for the management of diabetes and chronic kidney disease (CKD)
  • Discuss the evidence supporting the combination of a SGLT2 inhibitor and a GLP-1 receptor agonist

2. Hypoglycemia

  • Define hypoglycemia and its severity classification
  • Describe the prevalence and impact of hypoglycemia on people with diabetes
  • Determine strategies to reduce the risk of hypoglycemia
  • Adapting a person’s antihyperglycemic therapies and treatment plan to reduce the risk of hypoglycemia

3. Initiating Basal Insulin

  • Differentiate between different available basal insulins and individualizing the options for people with Type 2 Diabetes
  • Determine when and how to initiate basal insulin in a person with Type 2 Diabetes
  • Discuss the training and education required for a person to safely administer basal insulin

4. Beyond Basal Insulin

  • Discuss key considerations to assess in people with Type 2 Diabetes who are not reaching glycemic targets with basal insulin
  • Determine the different options in a person with Type 2 Diabetes currently taking basal insulin who is not reaching targets
  • Contrast the different risks and benefits of therapies that can be added to basal insulin

5. Continuous Glucose Monitoring

  • Review the key recommendations and evidence from the Diabetes Clinical Practice Guidelines
  • Determine the potential role for continuous glucose monitoring (CGM) technology in monitoring patients with type 2 diabetes
  • Discuss practical aspects of using CGM
  • Utilize CGM report data to manage type 2 diabetes

Categories: Conferences & Expos

Contact us